Regional News Archives - Page 88 of 190 - Journal for Clinical Studies

Current Edition

Regional News

Ogilvy Health’s new PR practice chief talks pharma image and social trends

There’s a shifting focus in pharma public relations from image to impact, says Ogilvy Health’s new PR practice president. Shannon Walsh, recently tapped to lead publ...

18 August 2021 Regional News Bristol Myers Squibb | Johnson & Johnson

Continue Reading →

Regional News

Merck’s Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected

Merck’s $1.1 billion bet on Peloton Therapeutics is starting to pay off. Belzutifan, one of the most lucrative assets Merck picked up through its 2019 Peloton buy, s...

18 August 2021 Regional News Belzutifan | central nervous system

Continue Reading →

Regional News

Eli Lilly’s Olympic run ends with enduring stories of Team USA athletes’ sport and health quests

Eli Lilly’s Olympic sponsorship ended last week with millions of media impressions, bolstered corporate pride and even a gold medal for one of its athletes. Volleybal...

18 August 2021 Regional News COVID-19 | Eli Lilly

Continue Reading →

Regional News

Pfizer’s tick-borne encephalitis vaccine TicoVac passes FDA muster, allowing travelers and the military easier access

Pfizer's vaccines group has been on a roll, generating world-leading COVID-19 shot sales and scoring a June approval for a much-anticipated Prevnar 13 follow up. Late...

18 August 2021 Regional News CDC | FDA

Continue Reading →

Regional News

After FibroGen’s FDA rejection in anemia, Akebia CEO aims to seize first-in-class opening with vadadustat

In the race for novel oral drugs to treat anemia of chronic kidney disease, AstraZeneca and FibroGen’s roxadustat held the front-runner position for quite some time. ...

18 August 2021 Regional News Akebia | FDA

Continue Reading →

Regional News

Viatris shows no signs of growing pains in its ‘trough year,’ but one analyst has longer-term worries

Viatris CEO Michael Goettler may well consider this a “trough” year for his newly formed company. But only months after he made that declaration, Viatris reported fig...

10 August 2021 Regional News biopharma | COVID-19

Continue Reading →

Regional News

Ginkgo and Aldevron tout mRNA manufacturing ‘breakthrough’—and the perks could stretch well beyond COVID-19, exec says

A multibillion-dollar SPAC deal? Check. An international acquisition? Check. An mRNA vaccine production "breakthrough?" Ginkgo Bioworks says it has that, too. With i...

10 August 2021 Regional News manufacturing | Moderna

Continue Reading →

Regional News

Roche snags coveted Polivy win in newly diagnosed lymphoma. But is it enough to change 2 decades of established treatment practices?

After two years of meager sales for Polivy, Roche is trumpeting a much-coveted clinical win that could open up a blockbuster market for the drug. Still, questions rem...

10 August 2021 Regional News DLBCL | Lymphoma

Continue Reading →

Regional News

AstraZeneca, Daiichi Sankyo build Enhertu’s blockbuster case with breast cancer win against Roche’s Kadcyla

AstraZeneca and Daiichi Sankyo’s Enhertu is shouldering big expectations. With a new head-to-head trial win against Roche’s Kadcyla, the companies are showing their a...

10 August 2021 Regional News AstraZeneca | Daiichi Sankyo’s Enhertu

Continue Reading →

Regional News

BioNTech, eyeing $18B-plus in COVID-19 vaccine sales this year, poised to join the ranks of the world’s top drugmakers

The COVID-19 pandemic helped put mRNA vaccines on the map. Now, thanks to the shots' quick uptake in rich countries, mRNA specialist BioNTech appears poised to join t...

10 August 2021 Regional News BioNTech | coronavirus

Continue Reading →